
Factus 40mg Tablet SR
Marketer
Delcure Life Sciences
Salt Composition
Febuxostat (40mg)
Overview Factus 40mg Tablet SR
Gout, characterized by excessive uric acid crystallizing in joints, causing inflammation and pain, is effectively managed and prevented with the 40mg sustained-release Factus tablet. This medication lowers uric acid levels. Factus 40mg SR can be administered with or without food; continuous use, as directed by your physician, is crucial to prevent symptom exacerbation from further crystal formation. Dietary modifications (e.g., limiting alcohol and red meat) and increased fluid intake are also beneficial. Potential side effects include liver enzyme abnormalities, nausea, arthralgia, and skin rashes. Initially, a temporary flare-up of gout symptoms (intense joint pain, heat, and redness) might occur; do not discontinue treatment. Your doctor might prescribe analgesics or other medications to alleviate these. Report any signs of liver dysfunction, such as persistent nausea, dark urine, or jaundice, immediately. Prior to starting Factus 40mg SR, inform your doctor of any pre-existing cardiac issues, history of stroke, thyroid disorders, or hepatic or renal impairment. Pregnancy or breastfeeding necessitates consultation with your doctor; this medication is generally avoided during these periods. Regular blood tests to monitor liver function are essential throughout treatment.
Primary Ingredients of Factus 40mg Tablet SR
No information provided. Please provide the text you wish to be rewritten.
Uses of Factus 40mg Tablet SR
Managing Gout
Major Benefits of Factus 40mg Tablet SR:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Factus 40mg Sustained-Release Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Factus 40mg Tablet SR:
- Nausea
- Skin rash
- Abnormal liver function
- Joint pain
- Rash
How to use Factus 40mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Factus 40mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.
How Factus 40mg Tablet SR works:
Each Factus 40mg sustained-release tablet inhibits xanthine oxidase, thereby lowering blood uric acid levels—the culprit behind gout.
SAFETY ADVICE
AlcoholCAUTION
Use of Factus 40mg Tablet SR with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Prolonged-release Factus 40mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Factus 40mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Factus 40mg Tablet SR, which can induce side effects such as dizziness, drowsiness, blurred vision, and paresthesia.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Factus 40mg Tablet SR. Dosage modification of Factus 40mg Tablet SR may be necessary. Physician consultation is advised. Data on Factus 40mg Tablet SR use in such patients is limited.
LiverCAUTION
Patients with severe hepatic impairment should use Factus 40mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised, as data on its use in such patients is limited.
What if you forget to take Factus 40mg Tablet SR :
Should you forget a Factus 40mg SR Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Factus 40mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Thiazole-based compound |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
